Platelet-rich therapies as an emerging platform for regenerative medicine-Reference-Cited by-同舟云学术

Platelet-rich therapies as an emerging platform for regenerative medicine

Published:2021-06-07 Issue:12 Volume:21 Page:1603-1608
ISSN:1471-2598
Container-title:Expert Opinion on Biological Therapy
language:en
Short-container-title:Expert Opinion on Biological Therapy

Author:

Orive Gorka¹²³,Anitua Eduardo¹²^ORCID

Affiliation:

1. BTI Biotechnology Institute, Vitoria, Spain

2. University Institute for Regenerative Medicine and Oral Implantology - UIRMI (Upv/ehu-fundación Eduardo Anitua), Vitoria, Spain

3. Department of Pharmacy, NanoBioCel Group, Laboratory of Pharmaceutics, School of Pharmacy, University of the Basque Country UPV/EHU, Paseo De La Universidad 7, Vitoria-Gasteiz, Spain

Funder

This paper is not funded.

Publisher

Informa UK Limited

Subject

Clinical Biochemistry,Drug Discovery,Pharmacology

Link

https://www.tandfonline.com/doi/pdf/10.1080/14712598.2021.1936495

Reference46 articles.

1. Gene therapy targets sickle-cell disease

2. Gene Therapy

3. Targeting cardiac fibrosis with engineered T cells

4. Cell-laden alginate hydrogels for the treatment of diabetes

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The growth factor content as an indicator of platelet counts in platelet-rich plasma;Clinica Chimica Acta;2025-01

2. Immunoregulatory role of platelet derivatives in the macrophage-mediated immune response;Frontiers in Immunology;2024-06-25

3. Plasma Rich in Growth Factors as an Adjuvant Treatment for the Management of Frontal Fibrosing Alopecia: A Retrospective Observational Clinical Study;Journal of Cutaneous Medicine and Surgery;2023-05-26

4. Application of Platelet-Rich Plasma as a Stem Cell Treatment - an Attempt to Clarify a Common Public Misconception;Current Molecular Medicine;2023-05-11